Nucleus® Implant reliability

With a cochlear implant, you want to choose a hearing solution for today and for the future. That’s why reliability is so important.

Grandson whispers to grandpa

What you'll find on this page

  • Why implant reliability is important.
  • Why Cochlear™ Nucleus® Implants are the most reliable.1-3
  • The story of Cochlear's first commercial child recipient, Holly Taylor, who's relied on her implant for more than 30 years.

Reliability you can count on

Choosing a cochlear implant is an important decision. Be it for yourself or a loved one, you want to trust that you are choosing the right hearing solution for the future.

Stat-ProfilePlus2023.png

Along with hearing performance, the reliability of the implant you choose can provide peace of mind for the years to come. That's why it matters that Cochlear Nucleus Implants are the most reliable in the industry.1-3

Most reliable1-3

No other manufacturer can match our implant reliability over time. This graph compares currently available implants with over eight years of reported reliability data. The implants shown have been available in market for comparable periods.

Implant reliability1-3

Bar graph showing latest generation implant reliability

^ Inconsistent CSP data reported over time.4
** Non-compliant with European Consensus Statement.#,5

Most reliable over time

Cochlear Nucleus Implants are the most reliable over time.1-3

Transparency is important to us, so we meet and report against independent global standards for implant reliability, publishing data for every implant generation, past and present.5-8

Implant reliability over time1-3

Line graph showing implant reliability over time

^ Inconsistent CSP data reported over time.4
** Non-compliant with European Consensus Statement.#,5

Most reliable for children1-3

Cochlear leads the market in implant reliability for children. This graph compares currently available implants with over eight years of reported reliability data. The implants shown have been available in market for comparable periods.

Implant reliability in children1-3

Bar graph showing latest generation implant reliability in children

^ Inconsistent CSP data reported over time.4
** Non-compliant with European Consensus Statement.#,5

Most chosen

With more than 500,000 registered Cochlear Nucleus Implants worldwide,2 Cochlear leads the way as the most chosen provider of implantable hearing solutions.

Number of registered implants1-4

Bar graph showing number of registered implants

 


Cochlear Nucleus System Reliability Report

Volume 21 - December 2022 | PDF

1.86 MB | PDF

Download now

For data based on the ANSI/AAMI CI86 Standard for cochlear implant systems click here. For information on the calculation of implant reliability click here.

Why cochlear implant reliability matters

Cochlear's first commercial child recipient, Holly Taylor, has relied on her Cochlear Implant for more than 30 years. Discover why Holly says, "I choose quality. I choose Cochlear."


Holly is an immediate family member of a former employee of Cochlear Limited.

Disclaimer

Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.

In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.

In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.

In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.

For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.

Any testimonial featured on this website is intended for an Australian audience only.


* CSP = Cumulative Survival Percentage. CSP includes both device and accident related issues.

# The European Consensus Statement on Cochlear Implant Failures and Explantation states, "Reporting of the CSR should be in accordance with ISO standard 5841–2:2000" and "Reports of CSR should give complete historical data of a given device." MED-EL does not report in accordance with ISO standard 5841–2:2000 and does not report CSR of Combi 40/Combi 40+ implant models.

References
  1. Based on implant generations released within a comparable period with 5+ years of CSP data.
  2. Cochlear Limited. D2073229 Cochlear Nucleus Reliability Report Volume 21 December 2022, March 2023
  3. Advanced Bionics Reliability Report December 2022. 028-Q048-02 Rev B. Advanced Bionics AG and affiliates. Data valid as of 1 October 2022.
  4. Cochlear Implant Reliability | MED-EL [Internet]. Medel.com. 2023. Available from: http://www.medel.com/hearing-solutions/cochlear-implants/reliability.
  5. European Consensus Statement on Cochlear Implant Failures and Explantations. Otol Neurotol. 2005 Nov;26(6):1097-9.
  6. International Standard ISO 5841-2:2000. Implants for Surgery — Cardiac Pacemakers — Part 2: Reporting of Clinical Performance of Populations of Pulse Generators or Leads. Geneva (Switzerland): International Organization for Standardization.
  7. Battmer RD, Backous DD, Balkany TJ, Briggs RJ, Gantz BJ, van Hasselt A, et al. International Classification of Reliability for Implanted Cochlear Implant Receiver Stimulators. Otol Neurotol. 2010 Oct;31(8):1190-3.
  8. ANSI/AAMI CI86. Cochlear implant systems: Requirements for safety, functional verification,. (2017). Arlington, VA: American National Standards Institute.